A high Cav-1 level could contribute to the entry of albumin and nab-paclitaxel (albumin-bound paclitaxel) into H23 lung cancer cells, therefore, enhancing cell apoptosis; while drug resistance is shown in these cells following Cav-1 reduction [135]. The gene discussed is CAV1; the disease is lung cancer.